Thomas Striepe
Chief Executive Officer at SANGUI BIOTECH INTERNATIONAL, INC.
Profile
Thomas Striepe is currently the President, CEO, CFO & Director at Sangui BioTech International, Inc. He is also the Vice President-Finance & Controlling at Dr. Ludz Vermögensberatungs & Vermittlungs GmbH and the Vice President-Accounting & Controller at Treukonzept Finance GmbH.
Previously, he worked as the CFO, Head-Investor & Press Relations at Feedback AG.
Mr. Striepe holds an MBA from the University of Hamburg.
Thomas Striepe active positions
| Companies | Position | Start |
|---|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Chief Executive Officer | 2005-02-06 |
| Dr. Ludz Vermögensberatungs & Vermittlungs GmbH | Director of Finance/CFO | 2003-12-31 |
| Treukonzept Finance GmbH | Comptroller/Controller/Auditor | 2003-12-31 |
Former positions of Thomas Striepe
| Companies | Position | End |
|---|---|---|
| FEEDBACK AG | Director of Finance/CFO | - |
Training of Thomas Striepe
| University of Hamburg | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Feedback AG
 Feedback AG Financial ConglomeratesFinance Feedback AG is a holding company, which engages in the provision of financial and consulting services to institutional and private clients. It specializes in the development, analysis and placement of closed-end funds. Feedback also offers consulting and support services in the area of return-oriented investments. The company was founded on October 29, 1996 and is headquartered in Hamburg, Germany. | Finance |
| Dr. Ludz Vermögensberatungs & Vermittlungs GmbH | |
| Treukonzept Finance GmbH |
- Stock Market
- Insiders
- Thomas Striepe
